Shanghai Henlius Biotech has appointed its current executive director, president and CEO Wenjie Zhang as chairman after Qiyu Chen resigned from the role “due to work adjustment.” Zhang, who is maintaining his position as CEO but will give up his presidential and directorial titles, will now lead the senior management team and oversee the daily management and operations of the company and its subsidiaries.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?